FINWIRES · TerminalLIVE
FINWIRES

BTIG Initiates ICU Medical at Buy With $170 Price Target

By

FINWIRES Analysis

BTIG's Buy initiation with a $170 target lands almost exactly on the $171.71 consensus mean, signaling alignment rather than a differentiated view on the medical-device maker. Such consensus-matching initiations mainly add a coverage voice rather than new information. Margin recovery and integration execution remain the operative catalysts to monitor.

What are the key takeaways?

  • $170 target essentially matches $171.71 mean
  • Initiation adds coverage, not new view
  • Margin recovery and integration are catalysts

ICU Medical (ICUI) has an average rating of buy and mean price target of $171.71, according to analysts polled by FactSet.

What else is happening in Research?

Research

Goldman Sachs Downgrades Signify to Neutral

Goldman Sachs on Friday downgraded Dutch lighting company Signify (LIGHT.AS) to neutral from buy, while maintaining its price target at 21 euros.

$LIGHT.AS
Research

Citi Upgrades Halma to Buy Rating, Boosts PT

Citi on Friday raised life-saving technology group Halma (HLMA.L) to buy from neutral and increased its price target to 46 pounds sterling from 37 pounds.

$HLMA.L
Research

Riyad Capital Reduces Al-Dawaa Medical Services' PT, Keeps at Neutral

Riyad Capital on Thursday decreased the price target for Saudi Arabian medical services company and pharmacy operator Al-Dawaa Medical Services (SASE:4163) to 45 Saudi riyals from 50 riyals and kept its neutral rating.

SASE:4163